Featured in Infectious DiseasesInfectious Diseases News & ResearchTecovirimat No Aid for Time to Lesion Resolution With MpoxAdditionally, interim analysis shows that the antiviral is safe but has no effect on pain among adults with mild-to-moderate clade II mpox By Lori Solomon (Healthday News) | December 20, 2024Burden of Superficial Cutaneous Fungal Infection Quantified in U.S.SCFIs account for about 0.54 percent of all ambulatory visits, with trend in annual SCFIs increasingBy Elana Gotkine (HealthDay News) | November 15, 2024COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory DiseaseDemographic factors, including sex, age younger than 40 years, age 40 years and older, showed diverse associations with risk for outcomesBy Elana Gotkine (HealthDay News) | November 08, 2024